We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

47 hedge funds and large institutions have $13.4M invested in Aptose Biosciences, Inc. in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

4% less funds holding

Funds holding: 49 → 47 (-2)

9% less capital invested

Capital invested by funds: $14.7M → $13.4M (-$1.28M)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
11
Closed
9
Calls
$32K
Puts
–
Net Calls
+$32K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
SPC
Sigma Planning Corp
Michigan
+$102K
2
TI
Telemetry Investments
New York
+$59.6K
3
Millennium Management
Millennium Management
New York
+$56.9K
4
AC
Annandale Capital
Texas
+$53.7K
5
FAM
Formidable Asset Management
Ohio
+$53.7K

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$499K
2
SMH
Sanders Morris Harris
Texas
-$377K
3
PAWC
P.A.W. Capital
Connecticut
-$336K
4
Morgan Stanley
Morgan Stanley
New York
-$45.9K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$41K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$20.6K -$16.7K -62 -44%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$18K – – –
US Bancorp
28
US Bancorp
Minnesota
$17.6K – – –
SMH
29
Sanders Morris Harris
Texas
$14.7K -$377K -1,405 -96%
EP
30
Equius Partners
California
$14.5K – – –
TCA
31
Transcend Capital Advisors
New Jersey
$13.9K – – –
SFA
32
Sequoia Financial Advisors
Ohio
$11.6K – – –
NDSI
33
Newman Dignan & Sheerar Inc
Rhode Island
$11K – – –
GG
34
Gleason Group
Kentucky
$10.6K – – –
WA
35
WealthTrust Axiom
Pennsylvania
$8.7K – – –
IAIM
36
International Assets Investment Management
Florida
$8.7K +$8.86K +33 New
NFSG
37
Newbridge Financial Services Group
Florida
$8.41K – – –
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$8K -$269 -1 -3%
WAM
39
Warberg Asset Management
Illinois
$6.67K – – –
PP
40
PDS Planning
Ohio
$5.8K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$4K +$1.61K +6 +75%
HWM
42
HighMark Wealth Management
Minnesota
$2.62K – – –
BHWM
43
Beaird Harris Wealth Management
Texas
$2.18K – – –
Rockefeller Capital Management
44
Rockefeller Capital Management
New York
$2K – – –
Northwestern Mutual Wealth Management
45
Northwestern Mutual Wealth Management
Wisconsin
$1.16K – – –
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$875 -$6.18K -23 -88%
Bank of America
47
Bank of America
North Carolina
$290 +$269 +1 New
National Bank of Canada
48
National Bank of Canada
Quebec, Canada
$21 – – –
UBS Group
49
UBS Group
Switzerland
$1 – – –
PAWC
50
P.A.W. Capital
Connecticut
– -$336K -1,256 Closed
1
2
3

APTO Hedge Fund Activity: Q4 2022 in Review

47 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2022, worth a combined $13.4M — down 8.7% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of APTO and 7 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 11 added.

The largest buyer was Sigma Planning Corp, adding an estimated $102K. The largest seller was Nantahala Capital Management, cutting an estimated $499K.

  • 47 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2022, down from 49 in Q3 2022.
  • Funds reported $13.4M of Aptose Biosciences, Inc. stock for Q4 2022, down 8.7% quarter-over-quarter.
  • 7 funds opened new Aptose Biosciences, Inc. positions in Q4 2022 and 9 closed out, a net change of -2 holders.
  • The largest Aptose Biosciences, Inc. buyer in Q4 2022 was Sigma Planning Corp, an estimated $102K added.
  • The largest Aptose Biosciences, Inc. seller in Q4 2022 was Nantahala Capital Management, an estimated $499K sold.

Based on aggregated 13F filings for Q4 2022.